Norway· NO-ID_8CEA6B37-6C8F-489B-8EA0-F78F8583D4CD
Emgality
A galcanezumab product containing galcanezumab, registered in Norway by Abacus Medicine A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Galcanezumab is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CD02 (galcanezumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Galcanezumab · ATC N02CD02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Galcanezumab
- Manufacturer
- Abacus Medicine A/S
- Country
- Norway (NO)
- ATC code
- N02CD02
- ATC class
- Galcanezumab
- Defined daily dose
- 4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_8CEA6B37-6C8F-489B-8EA0-F78F8583D4CD
- no_varenummer5487131NOK 5148.4
- gtin5712440018723
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Galcanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEMGALITYEli Lilly Nederland B.V., Utrecht
- BelgiumEmgality 120 mgEli Lilly Nederland
- SpainEMGALITY 120 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAEli Lilly Nederland B.V.
- IcelandEmgalityEli Lilly Nederland B.V.*
- SwedenEmgality 120 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- PolandEmgalityEli Lilly Nederland B.V.
- SwitzerlandEmgality 120 mg, solution injectable en stylo prérempliEli Lilly (Suisse) SA
- United KingdomEmgality 120mg/1ml solution for injection pre-filled pensOrganon Pharma (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Emgality
- Liechtenstein · Emgality
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/382ed844-81ec-4663-9ddb-deb305470e8e GET /v1/drugs/382ed844-81ec-4663-9ddb-deb305470e8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt penn",
"source": "fest",
"status": "A",
"atc_name": "Galkanezumab",
"merkevare_id": "ID_8CEA6B37-6C8F-489B-8EA0-F78F8583D4CD",
"name_form_strength": "Emgality inj, oppl 120 mg",
"prescription_group": "C"
}See everything about galcanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.